How to use US to guide periurethral collagen injection

Article

Periurethral bulking agents provide a unique, minimally invasive treatment option for stress urinary incontinence in female patients. Although many different injectable agents have been described, the gold standard remains glutaraldehyde cross-linked bovine collagen (Contigen). Limited efficacy and durability have been reported in a significant proportion of patients and presumed to result from collagen loss (eg, by tissue absorption/metabolism and luminal extravasation).

Current 3-D US data Close to two-thirds (62%) of patients who have achieved an initial satisfactory improvement in continence have been shown to have a circumferential distribution of collagen around the urethra, while this configuration was observed in only 20% of patients without satisfactory improvement in continence (Urology 2003; 62:232-6). Eighty percent of patients achieving a durable response (at least 1 year; mean, 2 years) had a circumferential configuration (Urology 2005; 65:60-6).

Recent Videos
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
DNA | Image Credit: © BillionPhotos.com - stock.adobe.com
Kyrollis Attalla, MD, an expert on prostate cancer
Kyrollis Attalla, MD, an expert on prostate cancer
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Quitting smoking - male hand crushing cigarette | Image Credit: © mbruxelle - stock.adobe.com
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Human kidney cross section on science background | Image Credit: © Crystal light - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.